Operating Lease, Right-of-Use Asset of Blueprint Medicines Corp from 01 Jan 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Blueprint Medicines Corp quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Mar 2025.
  • Blueprint Medicines Corp Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $61,607,000, a 14% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

Blueprint Medicines Corp Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $61,607,000 -$9,615,000 -14% 31 Mar 2025 10-Q 01 May 2025 2025 Q1
Q4 2024 $64,181,000 -$9,510,000 -13% 31 Dec 2024 10-Q 01 May 2025 2025 Q1
Q3 2024 $66,416,000 -$8,805,000 -12% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $68,881,000 -$8,648,000 -11% 30 Jun 2024 10-Q 01 Aug 2024 2024 Q2
Q1 2024 $71,222,000 -$8,446,000 -11% 31 Mar 2024 10-Q 02 May 2024 2024 Q1
Q4 2023 $73,691,000 -$8,163,000 -10% 31 Dec 2023 10-K 13 Feb 2025 2024 FY
Q3 2023 $75,221,000 -$8,696,000 -10% 30 Sep 2023 10-Q 26 Oct 2023 2023 Q3
Q2 2023 $77,529,000 -$8,504,000 -9.9% 30 Jun 2023 10-Q 02 Aug 2023 2023 Q2
Q1 2023 $79,668,000 -$8,451,000 -9.6% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $81,854,000 -$8,308,000 -9.2% 31 Dec 2022 10-K 15 Feb 2024 2023 FY
Q3 2022 $83,917,000 +$20,931,000 +33% 30 Sep 2022 10-Q 01 Nov 2022 2022 Q3
Q2 2022 $86,033,000 +$21,587,000 +33% 30 Jun 2022 10-Q 02 Aug 2022 2022 Q2
Q1 2022 $88,119,000 +$22,132,000 +34% 31 Mar 2022 10-Q 03 May 2022 2022 Q1
Q4 2021 $90,162,000 +$22,623,000 +33% 31 Dec 2021 10-K 16 Feb 2023 2022 FY
Q3 2021 $62,986,000 -$6,034,000 -8.7% 30 Sep 2021 10-Q 28 Oct 2021 2021 Q3
Q2 2021 $64,446,000 -$6,025,000 -8.6% 30 Jun 2021 10-Q 29 Jul 2021 2021 Q2
Q1 2021 $65,987,000 -$5,916,000 -8.2% 31 Mar 2021 10-Q 29 Apr 2021 2021 Q1
Q4 2020 $67,539,000 -$5,214,000 -7.2% 31 Dec 2020 10-K 17 Feb 2022 2021 FY
Q3 2020 $69,020,000 -$4,947,000 -6.7% 30 Sep 2020 10-Q 29 Oct 2020 2020 Q3
Q2 2020 $70,471,000 -$4,784,000 -6.4% 30 Jun 2020 10-Q 30 Jul 2020 2020 Q2
Q1 2020 $71,903,000 -$4,625,000 -6% 31 Mar 2020 10-Q 06 May 2020 2020 Q1
Q4 2019 $72,753,000 +$18,508,000 +34% 31 Dec 2019 10-K 17 Feb 2021 2020 FY
Q3 2019 $73,967,000 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $75,255,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $76,528,000 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 $54,245,000 01 Jan 2019 10-K 13 Feb 2020 2019 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.